Transition Bio, Inc.
PrivateLast Round
Series A
Jun 2, 2022
Total Funding Raised
$50M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Transition Bio, Inc. is a biotechnology company that operates a drug discovery platform using biophysical sciences and artificial intelligence to map and modulate biomolecular condensates.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transition Bio, Inc. Comparables
Compare Transition Bio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nereid | 89% | |
| Dewpoint Therapeutics | 88% | |
| Nuage Therapeutics | 85% | |
Transition Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 2, 2022 | ||||
| Seed | Sep 1, 2020 |
Transition Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Series A |
| Taiho Ventures | Series A |
| Lifeforce Capital | Series A, Seed |
| Northpond Ventures | Series A |
| Cambridge Enterprise | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 84% MoM, reaching 1.1K.
- Jun 22, 2026
Monthly visitors increased 45% MoM.
Transition Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Transition Bio, Inc.'s valuation, stock price, and market status.